Kathleen Lisaingo

Kathleen is a co-founder of AbCellera and leads the Cell Screening group. A co-inventor on several patents, Kathleen has been instrumental in developing custom single-cell assays and dramatically increasing the throughput of AbCellera’s core screening technology. An expert in cell biology and high-throughput screening, she has led the cell screening team through rapid growth while overseeing project teams, leading to the successful completion of over 35 discovery programs with pharma and biotech partners. Kathleen has a Ph.D. in Experimental Medicine and a BSc (Hons) in Biophysics from the University of British Columbia.